PL1943243T3 - Inhibitory kinazy - Google Patents

Inhibitory kinazy

Info

Publication number
PL1943243T3
PL1943243T3 PL06826650T PL06826650T PL1943243T3 PL 1943243 T3 PL1943243 T3 PL 1943243T3 PL 06826650 T PL06826650 T PL 06826650T PL 06826650 T PL06826650 T PL 06826650T PL 1943243 T3 PL1943243 T3 PL 1943243T3
Authority
PL
Poland
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
PL06826650T
Other languages
English (en)
Inventor
Jolie Anne Bastian
De Blas Jesus Andres Blas
Dios Alfonso De
Kevin John Hudziak
Tiechao Li
DE URALDE-GARMENDIA Beatriz LÓPEZ
Mary Margaret Mader
Michael Ray Myers
Mark Andrew Pobanz
Chuan Shih
Boyu Zhong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43298635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1943243(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL1943243T3 publication Critical patent/PL1943243T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06826650T 2005-10-28 2006-10-25 Inhibitory kinazy PL1943243T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73160405P 2005-10-28 2005-10-28
EP06380151 2006-06-02
US82196306P 2006-08-10 2006-08-10
EP06826650A EP1943243B1 (en) 2005-10-28 2006-10-25 Kinase inhibitors
PCT/US2006/041644 WO2007053394A1 (en) 2005-10-28 2006-10-25 Kinase inhibitors

Publications (1)

Publication Number Publication Date
PL1943243T3 true PL1943243T3 (pl) 2011-05-31

Family

ID=43298635

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06826650T PL1943243T3 (pl) 2005-10-28 2006-10-25 Inhibitory kinazy

Country Status (19)

Country Link
US (1) US7652015B2 (pl)
EP (1) EP1943243B1 (pl)
KR (1) KR101004156B1 (pl)
AR (1) AR056582A1 (pl)
AT (1) ATE493403T1 (pl)
AU (1) AU2006309044B2 (pl)
BR (1) BRPI0616901A2 (pl)
CA (1) CA2627673A1 (pl)
DK (1) DK1943243T3 (pl)
DO (1) DOP2006000234A (pl)
EA (1) EA015189B1 (pl)
PE (1) PE20070795A1 (pl)
PL (1) PL1943243T3 (pl)
PT (1) PT1943243E (pl)
RS (1) RS51949B (pl)
SI (1) SI1943243T1 (pl)
TN (1) TNSN08191A1 (pl)
TW (1) TWI325423B (pl)
WO (1) WO2007053394A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
US9024041B2 (en) 2010-04-08 2015-05-05 Respivert Ltd. P38 MAP kinase inhibitors
WO2011158044A2 (en) 2010-06-17 2011-12-22 Respivert Limited Respiratory formulations and compounds for use therein
WO2013013816A1 (en) 2011-07-26 2013-01-31 Grünenthal GmbH Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands
EP2890460B1 (en) 2012-08-29 2017-02-22 Respivert Limited Kinase inhibitors
US20150225373A1 (en) 2012-08-29 2015-08-13 Respivert Limited Kinase inhibitors
US9783556B2 (en) 2012-08-29 2017-10-10 Respivert Limited Kinase inhibitors
US9732063B2 (en) 2012-11-16 2017-08-15 Respivert Limited Kinase inhibitors
AU2014246866B2 (en) 2013-04-02 2018-05-10 Oxular Acquisitions Limited Kinase inhibitor
EP2981534B1 (en) 2013-04-02 2017-07-19 Topivert Pharma Limited Kinase inhibitors based upon n-alkyl pyrazoles
CA2934199A1 (en) 2013-12-20 2015-06-25 Respivert Limited Urea derivatives useful as kinase inhibitors
KR102736869B1 (ko) 2014-03-07 2024-12-02 바이오크리스트파마슈티컬즈,인코포레이티드 인간 혈장 칼리크레인 저해제
MA40774A (fr) 2014-10-01 2017-08-08 Respivert Ltd Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
EA201892213A1 (ru) 2016-04-06 2019-05-31 Топайверт Фарма Лимитед Ингибиторы киназ
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
DK3786160T3 (da) 2017-10-27 2022-08-22 Boehringer Ingelheim Int Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer
MX2023001818A (es) 2020-08-13 2023-03-13 Boehringer Ingelheim Int Compuestos para usarse en tratamiento de deterioro cognitivo asociado con la esquizofrenia.
IL301829A (en) 2020-10-13 2023-06-01 Boehringer Ingelheim Int Process of reworking

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136768A0 (en) * 1997-12-22 2001-06-14 Bayer Ag INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
PT1761520E (pt) * 2004-06-23 2008-09-15 Lilly Co Eli Inibidores de quinase

Also Published As

Publication number Publication date
AU2006309044B2 (en) 2011-10-13
TNSN08191A1 (en) 2009-10-30
WO2007053394A1 (en) 2007-05-10
KR20080053394A (ko) 2008-06-12
SI1943243T1 (sl) 2011-04-29
RS51949B (sr) 2012-02-29
DK1943243T3 (da) 2011-03-07
TWI325423B (en) 2010-06-01
US7652015B2 (en) 2010-01-26
ATE493403T1 (de) 2011-01-15
US20080269244A1 (en) 2008-10-30
CA2627673A1 (en) 2007-05-10
TW200800184A (en) 2008-01-01
EP1943243B1 (en) 2010-12-29
KR101004156B1 (ko) 2010-12-27
AR056582A1 (es) 2007-10-10
EA015189B1 (ru) 2011-06-30
DOP2006000234A (es) 2007-05-31
PT1943243E (pt) 2011-01-11
EA200801199A1 (ru) 2008-08-29
AU2006309044A1 (en) 2007-05-10
PE20070795A1 (es) 2007-08-24
EP1943243A1 (en) 2008-07-16
BRPI0616901A2 (pt) 2011-07-05

Similar Documents

Publication Publication Date Title
IL190078A0 (en) Kinase inhibitors
IL177278A0 (en) Pyrazolotriazines as kinase inhibitors
EP1794137A4 (en) SPECIFIC KINASE INHIBITORS
ZA200800423B (en) Sphingosine Kinase Inhibitors
ZA200900109B (en) Pyrrolotriazine kinase inhibitors
IL183276A0 (en) Kinase inhibitors
IL197381A0 (en) Kinase inhibitor
IL184674A0 (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
PL2079727T3 (pl) Inhibitory kinazy
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
EP1951715A4 (en) AMINOPYRIMIDINES USEFUL AS INHIBITORS OF KINASES
ZA200709269B (en) Protein kinase inhibitors
PL1943243T3 (pl) Inhibitory kinazy
ZA200607648B (en) Kinase inhibitors
EP1778693A4 (en) AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL
EP1912639A4 (en) Thiazolopyrimidine KINASE INHIBITORS
PL1896422T3 (pl) Inhibitory kinazy tyrozynowej
IL197981A0 (en) Kinase inhibitors
GB0608854D0 (en) P13 kinase inhibitors
GB0516967D0 (en) Inhibitors
ZA200804600B (en) Aminopyrimidines useful as kinase inhibitors
ZA200803287B (en) Kinase inhibitors
IL189985A0 (en) Kinase inhibitors
EP1940411A4 (en) MACROHETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
HK1121739A (en) Kinase inhibitors